Picture of Alkermes logo

ALKS Alkermes Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapSuper Stock

Annual cashflow statement for Alkermes, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-111-48.2-158356367
Depreciation
Deferred Taxes
Non-Cash Items88.791.7122107101
Unusual Items
Other Non-Cash Items
Changes in Working Capital13.1-25.512.7-36.7-98.2
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities82.810221401439
Capital Expenditures-42.2-28-38.3-48-33.5
Purchase of Fixed Assets
Other Investing Cash Flow Items30.7-38.2-26.3101-77.8
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-11.5-66.2-64.553.4-111
Financing Cash Flow Items-7.7-16.6-18.2-303-29.6
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-2.1729.1-1.57-290-494
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash69.264.6-45.1165-166